Cargando…

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107280/ https://www.ncbi.nlm.nih.gov/pubmed/30138452 http://dx.doi.org/10.1371/journal.pone.0203174

Ejemplares similares

Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
por: Azuma, Takeshi, et al.
Publicado: (2018)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Correction: Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

Correction: B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis
por: Lee, Jung Hee, et al.
Publicado: (2023)

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma
por: Wu, Yige, et al.
Publicado: (2023)

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
por: Gigante, Margherita, et al.
Publicado: (2015)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Correction: Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma
Publicado: (2015)

Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
por: Masuda, Akinori, et al.
Publicado: (2014)

Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma
por: Pagès, Gilles
Publicado: (2018)

Author Correction: Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
por: Xia, Zhi-Nan, et al.
Publicado: (2023)

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
por: Larrinaga, Gorka, et al.
Publicado: (2021)

Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma
por: Mischinger, Johannes, et al.
Publicado: (2019)

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma
por: Mao, Weipu, et al.
Publicado: (2021)

Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma
por: Galiniak, Sabina, et al.
Publicado: (2023)

Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Chen, Shao-An, et al.
Publicado: (2023)

Correction: MicroRNA-30a-5p(me): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples
por: Outeiro-Pinho, Gonçalo, et al.
Publicado: (2022)

A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma
por: Cho, Kang Su, et al.
Publicado: (2008)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

Correction to: Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma
por: Guo, Kai, et al.
Publicado: (2022)

Correction: Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Martin, Benedicte, et al.
Publicado: (2014)

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Park, Ji Young, et al.
Publicado: (2014)

Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas
por: Busch, Jonas, et al.
Publicado: (2015)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
por: Hoffmann, R, et al.
Publicado: (1999)

Correction to: Prognostic significance of serum inflammatory markers in esophageal cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2021)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

Correction: HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Publicado: (2020)

Correction: Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma
por: Yang, Chen, et al.
Publicado: (2022)

Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1
por: Yang, Feng-qiang, et al.
Publicado: (2015)

Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2019)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018)

Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
por: Caroline, Roelants, et al.
Publicado: (2019)

Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
por: Girgis, Hala, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vu5dn6a7pdg124kgelu7n54dd0